No black box warning on record for Coxir Intensive Egf Peptide Serum
As of the latest FDA labeling reviewed, Coxir Intensive Egf Peptide Serum (NIACINAMIDE, ADENOSINE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Coxir Intensive Egf Peptide Serum medicine page for the complete safety profile.